Combining angiotensin-receptor blockers with angiotensin-converting-enzyme inhibitors.
作者信息
Phillips Christopher O
机构信息
Morehouse School of Medicine, Atlanta, GA, USA.
出版信息
CMAJ. 2011 Apr 5;183(6):E309-11. doi: 10.1503/cmaj.110366. Epub 2011 Mar 21.
Abstract
摘要
相似文献
1
Combining angiotensin-receptor blockers with angiotensin-converting-enzyme inhibitors.
CMAJ. 2011 Apr 5;183(6):E309-11. doi: 10.1503/cmaj.110366. Epub 2011 Mar 21.
2
COVID-19 and inhibitors of the renin-angiotensin-aldosterone system.
Expert Rev Anti Infect Ther. 2021 Jul;19(7):815-816. doi: 10.1080/14787210.2021.1851197. Epub 2020 Nov 26.
3
The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysis.
CMAJ. 2011 Apr 5;183(6):655-62. doi: 10.1503/cmaj.101333. Epub 2011 Mar 21.
4
Risk of Sepsis and Mortality Among Patients With Chronic Obstructive Pulmonary Disease Treated With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers.
Crit Care Med. 2019 Jan;47(1):e14-e20. doi: 10.1097/CCM.0000000000003475.
5
Stopping RAS Inhibitors to Minimize AKI: More Harm than Good?
Clin J Am Soc Nephrol. 2019 Apr 5;14(4):617-619. doi: 10.2215/CJN.14021118. Epub 2019 Feb 27.
6
Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: should they be stopped or not before ambulatory anaesthesia?
Curr Opin Anaesthesiol. 2010 Dec;23(6):687-90. doi: 10.1097/ACO.0b013e32833eeb19.
7
Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cardiovascular outcomes in chronic dialysis patients: a population-based cohort study.
Arch Intern Med. 2012 Apr 9;172(7):591-3. doi: 10.1001/archinternmed.2012.139.
8
Effect of single or dual blockade of renin-angiotensin system in acute myocardial infarction patients according to renal function.
Int J Cardiol. 2012 Jun 14;157(3):408-11. doi: 10.1016/j.ijcard.2012.03.141. Epub 2012 Apr 16.
9
Evaluating for seasonal variation in angiotensin-converting enzyme inhibitor- and angiotensin receptor blocker-induced angioedema.
Ann Allergy Asthma Immunol. 2014 Feb;112(2):178-9. doi: 10.1016/j.anai.2013.11.016. Epub 2013 Dec 12.
10
Higher medication doses in heart failure?
Can Fam Physician. 2017 Jan;63(1):e20.
本文引用的文献
1
The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysis.
CMAJ. 2011 Apr 5;183(6):655-62. doi: 10.1503/cmaj.101333. Epub 2011 Mar 21.
2
HFSA 2010 Comprehensive Heart Failure Practice Guideline.
J Card Fail. 2010 Jun;16(6):e1-194. doi: 10.1016/j.cardfail.2010.04.004.
3
Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure.
PLoS One. 2010 Apr 1;5(4):e9946. doi: 10.1371/journal.pone.0009946.
4
Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults?
Ann Intern Med. 2009 May 19;150(10):717-24. doi: 10.7326/0003-4819-150-10-200905190-00010.
5
2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.
Circulation. 2009 Apr 14;119(14):e391-479. doi: 10.1161/CIRCULATIONAHA.109.192065. Epub 2009 Mar 26.
6
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.
Lancet. 2008 Aug 16;372(9638):547-53. doi: 10.1016/S0140-6736(08)61236-2.
7
Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials.
J Card Fail. 2008 Apr;14(3):181-8. doi: 10.1016/j.cardfail.2007.11.008.
8
Telmisartan, ramipril, or both in patients at high risk for vascular events.
N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.
9
Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials.
Arch Intern Med. 2007 Oct 8;167(18):1930-6. doi: 10.1001/archinte.167.18.1930.
10
Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
Expert Opin Pharmacother. 2007 Apr;8(5):529-35. doi: 10.1517/14656566.8.5.529.
Zotero 插件